A vaccine for the Severe Acute Respiratory Syndrome (SARS) will not be available if an epidemic should recur at the end of the year, but the first clinical trial of a vaccine could begin as early as January 2004, health experts convened by the United Nations World Health Organization (WHO) have concluded.